Investor’s Toolkit: Key Ratios for Assessing Larimar Therapeutics Inc (LRMR)’s Performance

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Larimar Therapeutics Inc (NASDAQ: LRMR) closed the day trading at $7.42 down -7.25% from the previous closing price of $8.00. In other words, the price has decreased by -$7.25 from its previous closing price. On the day, 0.58 million shares were traded. LRMR stock price reached its highest trading level at $7.64 during the session, while it also had its lowest trading level at $7.17.

Ratios:

For a better understanding of LRMR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.99 and its Current Ratio is at 17.99. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on April 03, 2024, initiated with a Outperform rating and assigned the stock a target price of $25.

On November 17, 2023, Citigroup Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $4.50.

On October 19, 2022, Guggenheim started tracking the stock assigning a Buy rating and target price of $12.Guggenheim initiated its Buy rating on October 19, 2022, with a $12 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 16 ’24 when Flynn James E bought 4,290,617 shares for $8.74 per share. The transaction valued at 37,499,993 led to the insider holds 6,151,406 shares of the business.

Hamilton Thomas Edward bought 57,208 shares of LRMR for $499,998 on Feb 16 ’24. The Director now owns 564,798 shares after completing the transaction at $8.74 per share. On Feb 14 ’24, another insider, THOMAS FRANK E, who serves as the Director of the company, bought 2,000 shares for $11.00 each. As a result, the insider paid 22,000 and bolstered with 2,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LRMR now has a Market Capitalization of 473410848 and an Enterprise Value of 251459968.

Stock Price History:

Over the past 52 weeks, LRMR has reached a high of $13.68, while it has fallen to a 52-week low of $2.18. The 50-Day Moving Average of the stock is -14.13%, while the 200-Day Moving Average is calculated to be 9.84%.

Shares Statistics:

Over the past 3-months, LRMR traded about 587.11K shares per day on average, while over the past 10 days, LRMR traded about 346850 shares per day. A total of 43.91M shares are outstanding, with a floating share count of 37.09M. Insiders hold about 41.87% of the company’s shares, while institutions hold 59.81% stake in the company. Shares short for LRMR as of 1721001600 were 3625213 with a Short Ratio of 6.17, compared to 1718323200 on 3268401. Therefore, it implies a Short% of Shares Outstanding of 3625213 and a Short% of Float of 8.7.

Most Popular